Economic evaluation of advanced practice physiotherapy models of care for upper extremity musculoskeletal disorders In Denmark: a registry-based cohort study.
Simon Lafrance, Cecilie Rud Budtz, Martin Byskov Kinnerup, François Desmeules, Jason Robert Guertin, Merete Nørgaard Madsen, David Høyrup Christiansen
{"title":"Economic evaluation of advanced practice physiotherapy models of care for upper extremity musculoskeletal disorders In Denmark: a registry-based cohort study.","authors":"Simon Lafrance, Cecilie Rud Budtz, Martin Byskov Kinnerup, François Desmeules, Jason Robert Guertin, Merete Nørgaard Madsen, David Høyrup Christiansen","doi":"10.1007/s10198-025-01817-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Advanced practice physiotherapy (APP) models of care, which provide greater autonomy and responsibility to physiotherapists, have emerged as promising solutions to increase healthcare access while providing cost-effective care for MSK disorders. A formal health economic evaluation of these models has yet to be undertaken in Denmark.</p><p><strong>Objectives: </strong>To perform a registry-based economic evaluation of APP care versus standard care models for managing upper extremity MSK disorders in four Danish orthopedic clinics in the societal perspective.</p><p><strong>Methods: </strong>Data related to sociodemographic, diagnoses, healthcare resource use, medication, costs, and sickness benefits within a two-year period after the initial consultation were extracted from Danish databases. Total healthcare costs including primary care (medical and rehabilitation), medication and hospital costs were calculated as well as productivity loss. Costs were converted to Euros 2022. Propensity score weighting was used to adjust for confounders.</p><p><strong>Results: </strong>A total of 13,517 patients were included in the main analysis. Healthcare cost distribution differed between the two models with higher rehabilitation (mean difference [MD]: €18; 95% CI: 8 to 28) but lower medication (MD: -€50; 95% CI: -58 to -43) costs with the APP model of care. However, there was no significant difference in total healthcare costs (MD: €86; 95% CI: -305 to 476) nor in productivity loss (MD: €197; 95% CI: -1678 to 2072) between the two models.</p><p><strong>Conclusion: </strong>APP care results in similar total healthcare costs and productivity loss when compared to standard care for adults with upper extremity MSK disorders.</p>","PeriodicalId":51416,"journal":{"name":"European Journal of Health Economics","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Health Economics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10198-025-01817-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Advanced practice physiotherapy (APP) models of care, which provide greater autonomy and responsibility to physiotherapists, have emerged as promising solutions to increase healthcare access while providing cost-effective care for MSK disorders. A formal health economic evaluation of these models has yet to be undertaken in Denmark.
Objectives: To perform a registry-based economic evaluation of APP care versus standard care models for managing upper extremity MSK disorders in four Danish orthopedic clinics in the societal perspective.
Methods: Data related to sociodemographic, diagnoses, healthcare resource use, medication, costs, and sickness benefits within a two-year period after the initial consultation were extracted from Danish databases. Total healthcare costs including primary care (medical and rehabilitation), medication and hospital costs were calculated as well as productivity loss. Costs were converted to Euros 2022. Propensity score weighting was used to adjust for confounders.
Results: A total of 13,517 patients were included in the main analysis. Healthcare cost distribution differed between the two models with higher rehabilitation (mean difference [MD]: €18; 95% CI: 8 to 28) but lower medication (MD: -€50; 95% CI: -58 to -43) costs with the APP model of care. However, there was no significant difference in total healthcare costs (MD: €86; 95% CI: -305 to 476) nor in productivity loss (MD: €197; 95% CI: -1678 to 2072) between the two models.
Conclusion: APP care results in similar total healthcare costs and productivity loss when compared to standard care for adults with upper extremity MSK disorders.
期刊介绍:
The European Journal of Health Economics is a journal of Health Economics and associated disciplines. The growing demand for health economics and the introduction of new guidelines in various European countries were the motivation to generate a highly scientific and at the same time practice oriented journal considering the requirements of various health care systems in Europe. The international scientific board of opinion leaders guarantees high-quality, peer-reviewed publications as well as articles for pragmatic approaches in the field of health economics. We intend to cover all aspects of health economics:
• Basics of health economic approaches and methods
• Pharmacoeconomics
• Health Care Systems
• Pricing and Reimbursement Systems
• Quality-of-Life-Studies The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfill the above-mentioned requirements.
Officially cited as: Eur J Health Econ